Pfizer
NEWS
This week’s announcement includes a step to the side for CMO Amit Rakhit, who will transition to the biotech’s advisory board.
Continuing studies and news about COVID-19 around the world keeps coming in. Here’s a look.
It’s a busy news day for COVID-19-related stories. Read on for more.
Here’s a look at some of the top COVID-19-related stories for today.
The groundbreaking success of the mRNA vaccines for COVID-19 by Pfizer-BioNTech and Moderna has led the way for other companies with a vested interest in vaccine development.
The U.S. FDA granted Fast Track Designation to three biopharma companies for the treatment of LGMD, episodic bleeding and leukemia.
Interim results from the Phase I study presented at the Peripheral Nerve Society Annual Meeting demonstrated that the investigational therapy, NTLA-2001, greatly reduced the disease-causing protein after a single infusion.
In what will be a big moment for CRISPR technology, Intellia and development partner, Regeneron Pharmaceuticals will share the world’s first data from a therapy that edits flawed genes inside the body.
The company indicated it was pausing distribution out of an abundance of caution and would continue investigations.
JOBS
IN THE PRESS